Abstract
Background Social deprivation markers are associated with worse clinical outcomes after cardiac revascularization procedures. However, the association between social deprivation and cardiac valvular procedural outcomes is less established. We sought to distinguish the relationship between social deprivation and outcomes in the management of severe aortic stenosis, specifically transcatheter aortic valve replacement (TAVR) versus conventional surgical aortic valve replacement (SAVR). Methods Demographics, patient comorbidities, procedural details, and outcomes for adults undergoing TAVR and SAVR between April 2017 and March 2022 were obtained from clinical and administrative databases and linked to neighbourhood-level measures of social deprivation using the Ontario Marginalization Index (ON-MARG) in Ontario, Canada. The three dimensions of social deprivation assessed were (1) material deprivation, (2) residential instability and (3) ethnic concentration. Our outcomes were 30-day mortality, 30-day readmission, 1-year mortality and 1-year readmission. Separate Cox proportional hazard models for post-procedural mortality and cause-specific hazard models for post-procedural re-admission were used to determine the association between social deprivation and post-procedural outcomes after TAVR versus SAVR. Results We identified 6,218 TAVR procedures and 3,342 isolated SAVR procedures within our study period. After multivariable adjustment, we found that TAVR was associated with lower 30-day mortality (HR 0.58; 95% CI [0.37, 0.92]; p = 0.02), lower 30-day readmission rates (HR 0.75; 95% CI [0.63, 0.89]; p-value = 0.001) and a higher 1-year readmission rate (HR 1.14; 95% CI [1.02, 1.27]; p-value = 0.01) when compared to SAVR. When the three ON-MARG domains by treatment interactions were included in the analysis, the associations between TAVR and SAVR and these outcomes were not modified by the degree of neighbourhood social deprivation. Conclusion TAVR is associated with lower 30-day mortality and 30-day re-admission rates and higher 1-year re-admission compared to SAVR. These associations were not modified by social deprivation, including ethnic concentration, material deprivation and residential instability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). This document used data adapted from the Statistics Canada Postal CodeOM Conversion File, which is based on data licensed from Canada Post Corporation, and data adapted from the Ontario Ministry of Health Postal Code Conversion File, which contains data copied under license from ©Canada Post Corporation and Statistics Canada. Parts of this material are based on data and information compiled and provided by the Ontario Ministry of Health. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. Parts of this material are based on data and information compiled and provided by: the Canadian Institute of Health Information (CIHI) and CorHealth Ontario. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed in the material are those of the authors, and not necessarily those of CIHI. The authors acknowledge that the clinical registry data used in this publication is from participating hospitals through CorHealth Ontario, which serves as an advisory body to the MOH, is funded by the MOH, and is dedicated to improving the quality, efficiency, access and equity in the delivery of the continuum of adult cardiac, vascular and stroke services in Ontario, Canada. We thank IQVIA Solutions Canada Inc. for use of their Drug Information File. Dr. Wijeysundera is supported by a Canada Research Chair in Structural Heart Disease Policy and Outcomes.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This population-level study was conducted using administrative and clinical datasets located and analyzed at ICES (previously the Institute for Clinical and Evaluative Sciences) and linked using unique encoded patient identifiers. ICES is an independent, not-for-profit research institute with a wide range of Ontario health data, including anonymous patient records and multiple clinical databases. ICES is a prescribed entity under Ontario?s Personal Health Information Protection Act, allowing researchers to link de-identified population-based data with clinical registries to conduct approved research studies under regulated privacy and security policies and procedures (see link to Data and Privacy at www. ices.on.ca). The use of ICES data in this project was authorized under section 45 of Ontario?s Personal Health Information Protection Act, which does not require review by a Research Ethics Board and the need for individual patient consent was waived. Therefore, institutional review board approval was waived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.